SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort
Highlights Cohort 4 of the SECuRE trial is the first to assess multiple cycles of 67Cu-SAR-bisPSMA at the highest dose of 12GBq. The Safety Review Committee (SRC) assessed early data from the first 3 participants in cohort 4 who received 2 doses of 67Cu-SAR-bisPSMA. Two of these participants had completed the...
E-Home Household Services Holdings Limited’s subsidiary Zhongrun Pharmaceutical and New Zealand’s NBL Pharmaceuticals Sign Cooperation Agreement to Expand International Markets
FUZHOU, China, Sept. 12, 2024 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that after the detailed business and market due diligence conducted by the Company and the detailed business and market due diligence conducted by New Zealand's NBL Pharmaceuticals (New Zealand) Limited ("NBL Corp.") from...
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively: THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS RESIGHT, and the EVA...
GenScript Appoints New Board Members to Drive Global Growth
PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript"), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group's Board but also highlight GenScript's commitment to building an international,...
Genea Biomedx solidifies its exclusive partnership in Australia with Genea Fertility
SYDNEY, Sept. 12, 2024 /PRNewswire/ -- Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproductive technology internationally. Previously an integral part of Genea Fertility, Genea Biomedx was central to scientific and technological advancements. Since 2015, Genea Fertility...
South Korean Startup DoctorPresso Launches Groundbreaking App That Detects Depression Through Voice
A New Era of Mental Health: Meet REDI, the App That Listens for Depression SEOUL, South Korea, Sept. 12, 2024 /PRNewswire/ -- In a world where mental health challenges are on the rise, South Korean startup DoctorPresso is taking an innovative step forward. The company has introduced REDI, a voice-based diary app that can detect early signs of depression by...
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
The global collective intelligence network aims to accelerate precision oncology research and care BOSTON and ROLLE, Switzerland, Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update that several world-renowned healthcare organizations have joined SOPHiA UNITY. SOPHiA UNITY...
Berlin Heals Strengthens Executive Leadership Team
Berlin Heals appoints proven cardiac rhythm management and heart failure leader John Brumfield as Chief Executive Office BERLIN, Sept. 12, 2024 /PRNewswire/ -- Berlin Heals Holding AG and its subsidiaries Berlin Heals GmbH and Berlin Heals Corp. which are developing a completely new and groundbreaking method for the treatment of Heart Failure,...
Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI
SINGAPORE, Sept. 12, 2024 /PRNewswire/ -- Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest diagnostics and life sciences companies in the world. This collaboration represents a significant milestone to advance cancer diagnostics and treatment and accelerate...
NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages
Translations are underway for the entire library of NCCN Guidelines for Patients to empower people with cancer and caregivers worldwide to make informed treatment decisions that are best for them. PLYMOUTH MEETING, Pa., Sept. 12, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—and the NCCN Foundation®...
